Basic HTML Version
• Presenter name
• Title
• Date
•
Subtitle of
other
information
New Anticoagulants
Dabigatran (PRADAXA)
Rivaroxiban (XARELTO)
Approved by FDA for Tx of A Fib (and other indications)
Superior to warfarin
Work at different sites in coagulation sequence
Neither has good agent for reversal